Product Information
METHYLPHENIDATE ER(LA) 30 MG CP is a generic product labeled by Sandoz Inc., priced at $2.0275 per EA under NDC 00781238501. Its NADAC has been published 56 times since Jul 30, 2025.
FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the methylphenidate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Sandoz Inc.NDC
00781238501
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021284FDA Approved
6/5/2002
TE Code
AB1
On Market Since
11/24/2015
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has been published 56 times since Jul 30, 2025, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0275 per EA |
|---|---|
| All-time high | $2.9073 (Dec 10, 2025) |
| All-time low | $2.0275 (Aug 19, 2026) |
| 52-week high | $2.9073 |
| 52-week low | $2.0275 |
| Median price | $2.1603 |
| Average price | $2.2772 |
| Largest weekly change | +16.7% (Oct 22, 2025) |
| Weeks tracked | 56 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER(LA) 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 30 MG CP, manufactured by Sandoz Inc., is $2.0275 per EA (NDC 00781238501), effective Aug 19, 2026.
How has the price of METHYLPHENIDATE ER(LA) 30 MG CP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has declined 16.8%. It has been tracked across 56 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 30 MG CP?
Since Jul 30, 2025, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has ranged from a low of $2.0275 (Aug 19, 2026) to a high of $2.9073 (Dec 10, 2025), with a median of $2.1603 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 30 MG CP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER(LA) 30 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE ER(LA) 30 MG CP?
METHYLPHENIDATE ER(LA) 30 MG CP (NDC 00781238501) is labeled by Sandoz Inc., and CMS classifies it as a generic product.